IN2014DN08296A - - Google Patents

Info

Publication number
IN2014DN08296A
IN2014DN08296A IN8296DEN2014A IN2014DN08296A IN 2014DN08296 A IN2014DN08296 A IN 2014DN08296A IN 8296DEN2014 A IN8296DEN2014 A IN 8296DEN2014A IN 2014DN08296 A IN2014DN08296 A IN 2014DN08296A
Authority
IN
India
Prior art keywords
palladium
formula
preparation
pharmaceutically acceptable
provides
Prior art date
Application number
Other languages
English (en)
Inventor
Palanisamy Senthilkumar Udayampalayam
Sureshkumar Kanagaraj
Nagesh Babu Kommoju
Syril Sudhan Henry
Pravin Kamaraj Ponraj
Suresh Thangaiyan
Original Assignee
Orchid Chemicals & Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orchid Chemicals & Pharm Ltd filed Critical Orchid Chemicals & Pharm Ltd
Priority to IN8296DEN2014 priority Critical patent/IN2014DN08296A/en
Publication of IN2014DN08296A publication Critical patent/IN2014DN08296A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02Preparation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN8296DEN2014 2012-04-04 2013-04-04 IN2014DN08296A (enrdf_load_stackoverflow)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN8296DEN2014 IN2014DN08296A (enrdf_load_stackoverflow) 2012-04-04 2013-04-04

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
IN1371CH2012 2012-04-04
IN5111CH2012 2012-12-07
IN8296DEN2014 IN2014DN08296A (enrdf_load_stackoverflow) 2012-04-04 2013-04-04
PCT/IN2013/000229 WO2013150550A2 (en) 2012-04-04 2013-04-04 An improved process for the preparation of carbapenem antibiotic

Publications (1)

Publication Number Publication Date
IN2014DN08296A true IN2014DN08296A (enrdf_load_stackoverflow) 2015-05-15

Family

ID=49301129

Family Applications (1)

Application Number Title Priority Date Filing Date
IN8296DEN2014 IN2014DN08296A (enrdf_load_stackoverflow) 2012-04-04 2013-04-04

Country Status (5)

Country Link
US (1) US20150038726A1 (enrdf_load_stackoverflow)
EP (1) EP2834242A4 (enrdf_load_stackoverflow)
HK (1) HK1207079A1 (enrdf_load_stackoverflow)
IN (1) IN2014DN08296A (enrdf_load_stackoverflow)
WO (1) WO2013150550A2 (enrdf_load_stackoverflow)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104788453B (zh) * 2014-01-16 2017-02-15 浙江九洲药业股份有限公司 厄他培南单钠盐一锅法制备工艺
KR102360512B1 (ko) * 2014-03-27 2022-02-10 존슨 맛쎄이 퍼블릭 리미티드 컴파니 카바페넴 항생물질의 제조 방법
CN113880839A (zh) * 2021-11-01 2022-01-04 石药集团中诺药业(石家庄)有限公司 一种厄他培南钠粗品的合成新方法
CN118791495B (zh) * 2024-09-13 2024-11-26 青松(天津)制药有限公司 一种碳青霉烯抗生素及其制备方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002341747B2 (en) * 2001-09-26 2007-10-18 Merck Sharp & Dohme Corp. Process for making carbapenem compounds
JP2005508321A (ja) * 2001-09-26 2005-03-31 メルク エンド カムパニー インコーポレーテッド 結晶形態のエルタペネムナトリウム
CN100457760C (zh) * 2005-10-20 2009-02-04 上海交通大学 尔他培南钠盐的制备方法
US8293894B2 (en) * 2006-11-20 2012-10-23 Orchid Chemicals & Pharmaceuticals Limited Process for the preparation of carbapenem antibiotic
IT1390756B1 (it) * 2008-07-04 2011-09-23 Acs Dobfar Spa Processo per la sintesi di carbapenem mediante l'uso di nickel raney
CN101560215B (zh) * 2009-05-27 2011-06-08 复旦大学 一种去除法罗培南钠残留钯的方法
JP2011057602A (ja) * 2009-09-09 2011-03-24 Dainippon Sumitomo Pharma Co Ltd 残留パラジウムの除去方法
WO2012038979A2 (en) * 2010-09-24 2012-03-29 Sequent Anti Biotics Private Limited A process for preparation of ertapenem

Also Published As

Publication number Publication date
HK1207079A1 (en) 2016-01-22
EP2834242A4 (en) 2016-01-06
US20150038726A1 (en) 2015-02-05
WO2013150550A3 (en) 2013-12-05
EP2834242A2 (en) 2015-02-11
WO2013150550A2 (en) 2013-10-10

Similar Documents

Publication Publication Date Title
MD20150091A2 (ro) Compuşi antivirali
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
IN2015DN01156A (enrdf_load_stackoverflow)
IN2014MN02658A (enrdf_load_stackoverflow)
IN2014CN02806A (enrdf_load_stackoverflow)
IN2014MN02459A (enrdf_load_stackoverflow)
NZ739760A (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
IN2014CN02805A (enrdf_load_stackoverflow)
GEP201706695B (en) Substituted 4-phenyl-pyridi-nes for the treatment of nk-1 receptor related diseases
IN2014MN02652A (enrdf_load_stackoverflow)
TW201240990A (en) Antiviral compounds
GEP20247677B (en) Processes for preparing quinoline compounds and pharmaceutical compositions containing such compounds
IN2014MN02598A (enrdf_load_stackoverflow)
AU2012213775A8 (en) 7-azaindole derivatives
PH12015501363B1 (en) Chloro-pyrazine carboxamide derivatives with epithelial sodium channel blocking activity
PH12014502586A1 (en) Novel ring-substituted n-pyridinyl amides as kinase inhibitors
MY162397A (en) Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
PH12013501591A1 (en) Il17 and ifn-gamma inhibition for the treatment of autoimmune inflammation
GEP201706626B (en) Synthesis of (s)-nifuratel
IN2013MU03862A (enrdf_load_stackoverflow)
MX347541B (es) Analogos de acido sialico.
IN2014DN08296A (enrdf_load_stackoverflow)
IN2015DN02444A (enrdf_load_stackoverflow)
NZ712341A (en) A crystalline form of an anxiolytic compound
AU2013347232A8 (en) 3-Aminocyclopentane carboxamide derivatives